Cormorant Asset Management’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.7M | Buy |
|
|||||
|
2025
Q1 | $90.2M | Buy |
|
|||||
|
2024
Q4 | $91M | Hold |
|
|||||
|
2024
Q3 | $90.9M | Buy |
|
|||||
|
2024
Q2 | $54.1M | Hold |
|
|||||
|
2024
Q1 | $54.8M | Buy |
|
|||||
|
2023
Q4 | $27.9M | Sell |
|
|||||
|
2023
Q3 | $16.9M | Hold |
|
|||||
|
2023
Q2 | $22.8M | Hold |
|
|||||
|
2023
Q1 | $19.7M | Hold |
|
|||||
|
2022
Q4 | $26.3M | Sell |
|
|||||
|
2022
Q3 | $30M | Sell |
|
|||||
|
2022
Q2 | $30.6M | Sell |
|
|||||
|
2022
Q1 | $45.4M | Buy |
|
|||||
|
2021
Q4 | $54.5M | Buy |
|
|||||
|
2021
Q3 | $56M | Buy |
|
|||||
|
2021
Q2 | $66.5M | Buy |
|
|||||
|
2021
Q1 | $74.3M | Buy |
|